Levels of soluble FasL and FasL gene expression during the development of graft‐versus‐host disease in DLT‐treated patients

Three patients with different clinical symptoms of graft‐versus‐host disease (GVHD) who had received donor lymphocyte transfusion (DLT) for the treatment of relapsed leukaemia after an allogeneic bone marrow transplantation (BMT) from HLA‐matched sibling donors were analysed for the presence of solu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 1999-03, Vol.104 (4), p.795-800
Hauptverfasser:	Das, Hiranmoy, Imoto, Shion, Murayama, Tohru, Kajimoto, Kazuyoshi, Sugimoto, Takeshi, Isobe, Takashi, Nakagawa, Toshitaro, Nishimura, Ryuichiro, Koizumi, Tamio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis BMT, DLT Bone Marrow Transplantation - methods Fas Ligand Protein FasL gene expression Female Graft vs Host Disease - etiology GVHD Humans Leukemia - therapy Lymphocyte Transfusion - adverse effects Male Medical sciences Membrane Glycoproteins - genetics Membrane Glycoproteins - metabolism Monocytes - metabolism Recurrence RNA, Messenger - metabolism sFasL Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!